Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Global healthcare communications

    Genesis giveaway of a minifigure

    Genesis Research Group contributes strong scientific program to ISPOR Europe and warmly invites visitors to booth 212

    Genesis Research Group is proud to be attending ISPOR Europe 2025 in Glasgow from 10-12th November with a strong scientific program that includes an HEOR Theater session, contributions to 10...

    Genesis Research Group

    Dave Miller on Biotechs image

    Dave W. Miller interviewed by Paige McGarry on the unique challenges faced by biotech companies

    HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.

    Genesis Research Group

    - PMLiVE

    Insights From ISPOR 2025: Breaking the Data Barrier in Rare Diseases – Can AI Bridge the Gap?

    Last month, the ISPOR annual meeting in Montreal was brimming with opportunities to explore the latest developments and insights in health economics and outcomes research (HEOR) and market access. In...

    Petauri Evidence

    - PMLiVE

    Sustainability and Environmental Impact in Market Access and Health Economics

    As the concept of sustainability gains traction in healthcare, it is beginning to influence how value is assessed and communicated across the Pharmaceutical and Medtech industries. In this article, experts...

    Petauri Evidence

    - PMLiVE

    Insights From ISPOR 2025: R In Health Technology Assessment – Is It The Future?

    ISPOR’s annual meeting in Montreal this May was packed with opportunities to explore the latest trends, insights, and research in HEOR and market access. In this series, our experts share...

    Petauri Evidence

    - PMLiVE

    Petauri unites Mtech Access and Delta Hat under one team: Petauri Evidence

    Rapidly growing pharmaceutical services platform unveils new integrated structure for global evidence solutions.

    Petauri Evidence

    ISPOR partner seal

    Genesis Research Group announces inaugural membership of ISPOR Corporate Partnership Program

    Genesis Research Group, a pioneer of tech-enabled real-world evidence (RWE), health economics and outcomes research (HEOR), and market access services, today announces it has joined selected organizations as an inaugural...

    Genesis Research Group

    - PMLiVE

    Your essential guide to the World EPA Congress 2025: Top sessions and pre-reading

    The World EPA organisers have curated an exceptional programme featuring thought-provoking presentations and dynamic panel sessions led by industry leaders driving market access strategy and practice. Following the opening keynote...

    Petauri Evidence

    - PMLiVE

    What does HEOR really mean in 2025?

    Global healthcare systems are under unprecedented strain. As life expectancies rise and populations age, the proportion of people aged 60+ years is expected to soar. This both signals remarkable progress...

    Petauri Evidence

    - PMLiVE

    Health economics training unpacked: A conversation with the trainers

    Did you know we offer a suite of education and training options? Our workshops, insight sessions, and training help Pharma and Medtech teams upskill in key HEOR disciplines and prepare...

    Petauri Evidence

    - PMLiVE

    Mtech Access are exhibiting at ISPOR in Europe

    • Mtech Access – Powered by Petauri™ are excited to be returning to ISPOR Europe this November. The team will be joined by colleagues from across Petauri, including Delta Hat...

    Petauri Evidence

    - PMLiVE

    Joint Clinical Assessments: bureaucratic nightmare, AI opportunity, or both?

    By Manca Povsic and Andrew Dobb

    Amiculum

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links